Pactiv Evergreen Q2 Sales $1.43B Miss $1.53B Estimate
Portfolio Pulse from Benzinga Newsdesk
Pactiv Evergreen (NASDAQ:PTVE) reported Q2 sales of $1.43 billion, missing the analyst consensus estimate of $1.53 billion by 6.80 percent. This represents a 13.05 percent decrease compared to the same period last year.
August 04, 2023 | 12:09 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Pactiv Evergreen's Q2 sales missed estimates and decreased compared to last year, which could negatively impact the stock price.
Pactiv Evergreen's Q2 sales missed the analyst consensus estimate and decreased compared to the same period last year. This underperformance could lead to a decrease in the company's stock price as it indicates potential issues with the company's revenue generation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100